VANGUARD GROUP INC - SUMMIT THERAPEUTICS INC ownership

SUMMIT THERAPEUTICS INC's ticker is SMMT and the CUSIP is 86627T108. A total of 53 filers reported holding SUMMIT THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.26 and the average weighting 0.0%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of SUMMIT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$11,398,913
-25.6%
6,095,675
-0.1%
0.00%
Q2 2023$15,312,231
+497.2%
6,100,490
+316.4%
0.00%
Q1 2023$2,563,976
-58.2%
1,465,129
+1.5%
0.00%
Q4 2022$6,135,121
+564.7%
1,443,558
+86.0%
0.00%
Q3 2022$923,000
+18.9%
775,9220.0%0.00%
Q2 2022$776,000
-65.2%
775,922
-14.9%
0.00%
Q1 2022$2,233,000
-8.5%
911,396
+0.5%
0.00%
Q4 2021$2,440,000
-46.2%
906,887
+0.1%
0.00%
Q3 2021$4,537,000
-30.9%
905,530
+2.9%
0.00%
Q2 2021$6,564,000
+103.5%
879,898
+60.1%
0.00%
Q1 2021$3,226,000
+24.9%
549,5420.0%0.00%
Q4 2020$2,583,000549,5420.00%
Other shareholders
SUMMIT THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Alpine Global Management, LLC 300,000$300,0000.08%
Polar Capital Holdings Plc 5,599,407$5,599,0000.03%
VANCE WEALTH, INC. 13,299$13,0000.01%
LEVIN CAPITAL STRATEGIES, L.P. 39,176$39,0000.01%
BENDER ROBERT & ASSOCIATES 14,059$14,0000.01%
HoyleCohen, LLC 30,432$30,0000.00%
Inscription Capital, LLC 17,000$17,0000.00%
Ergoteles LLC 100,722$101,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 89,100$89,0000.00%
ADIRONDACK TRUST CO 2,500$3,0000.00%
View complete list of SUMMIT THERAPEUTICS INC shareholders